Archives for June 2015

June 2015 - Page 21 of 25 - Money Morning - Only the News You Can Profit From

Top Biotechnology Companies Profiting from ASCO 2015

by

The American Society of Clinical Oncology (ASCO) held its annual meeting in Chicago this week.

More than 30,000 people attend the event, which features more than 4,000 presentations from some of the top biotechnology companies in the world.

For investors, this provides us an in-depth look at some of the world’s best biotechnology companies to invest in.

The Short Attack on Ekso Bionics (OTC: EKSO) Stock and How to Handle It

by

On June 2, Ekso Bionics Holdings Inc. (OTC: EKSO) stock dropped 24. 28% — thanks to an anonymous individual writing under the name "The Pump Stopper" who launched a vicious attack on the stock.

But if you've been in this game long enough, you know what to look for and why stuff like this isn't a big deal in the grand scheme of things.

Here's why you shouldn't be worried...

Why Organovo Stock Is a Top Biotech Stock to Buy in 2015

by

One of our favorite biotech stocks of 2015, Organovo stock, has climbed 41% since the end of March. And that's just the start for this revolutionary biotech investment.

You see, Organovo Holdings Inc. (NYSEMKT: ONVO) is part of one of the most exciting biotech industries on the market. It's called 3D bioprinting, and the applications are huge.

Here's a closer look at the 3D bioprinting market and why it's providing us with such a great investment opportunity.

Cybersecurity Stocks in Focus in Stock Market News Today

by

Good morning! In stock market news today, Friday, June 5, U.S. stock futures forecasted a 38-point decline from yesterday's close.

A cyberattack on the data of four million federal employees across nearly every government agency was announced by U.S. officials late Thursday. Additionally, the May jobs report is in focus in today's trading session.

Here are the top stories in stock market news today...

The Ugly Truth Behind the Fed's Quantitative Easing

by

Editor's note: In this groundbreaking analysis, Shah reveals how quantitative easing – a misguided multi-trillion dollar central bank policy and the greatest financial disruptor of our time – has distorted the global economy, made many traditional investments unprofitable, and stoked wealth and income inequality. But Shah says there are steps we can take to limit some of the damage – if we act now.

The growing income and wealth gap between the rich and poor, most of whom used to be called middle class, has many fathers. But behind the scenes one primary cause emerges. It's the greatest financial disruptor of modern times: Quantitative Easing (QE).

While the jury's out on whether QE will eventually be the step-ladder that lifts us out of the lingering Great Recession, as its proponents argue, the facts demand that the verdict on QE's egregious enrichment of the rich and subjugation of everyone else is: "guilty."

And the trouble won't stop now that the United States has begun winding down its quantitative easing – the Eurozone and Japan each have massive QE programs.

Here are the facts. Policymakers and struggling middle class and poor people must take a strong stand to fight this financial plague. Here's how...

The True Story Behind the Greek Debt Crisis: Why Hasn’t Greece Defaulted on Its Debt Yet?

by

For most of the Greek debt crisis the reality has been well-known. Even if it was only initially discussed among the staffers and in the back offices of the International Monetary Fund, a Greek default has always been inevitable.

So now that Greece is €328 billion in the hole – a 175% debt-to-GDP ratio – exactly why hasn’t Greece defaulted on its debt yet?

Here’s the real story behind the Greek debt crisis…